Midgard

KCAS Bio

Olathe, KS, United States kcasbio.com From their website, Nov 2026

  • GLP

Work here? Claim this listing

About

KCAS Bio is a bioanalytical and biomarker contract research organization serving pharmaceutical, biotechnology, and emerging biopharmaceutical companies. It supports drug development from discovery through clinical development with sites in the United States and Europe, plus a partner site in Melbourne, Australia.

Services

  • Small Molecule Bioanalysis

    GLP/GCP-compliant bioanalysis of small molecules using LC-MS/MS platforms to quantify drugs, metabolites, and biomarkers from discovery through clinical stages.

  • LBA for Large Molecules

    Ligand binding assay services for large molecules, including tailored assay development from early discovery through clinical studies.

  • Hybrid LC-MS/MS for Large Molecules

    High-sensitivity bioanalytical services for complex and emerging large molecule therapeutics using hybrid LC-MS/MS.

  • Immunogenicity Testing

    Testing to assess immune responses to therapeutic candidates.

  • Pharmacokinetics (PK)

    Bioanalytical support for pharmacokinetic studies.

  • Pharmacodynamics (PD)

    Bioanalytical support for pharmacodynamic studies.

  • Biomarker Testing

    Biomarker analysis to support drug development programs.

  • Flow Cytometry

    Flow cytometry services for bioanalysis and immune-response work.

3 more services
  • Molecular Biology
  • Dose Formulation
  • Central Lab Technology

Capabilities

Assays and studies
  • Bioanalysis
  • LC-MS/MS
  • Small molecules
  • Flow cytometry
  • Immunogenicity
  • PK/PD
17 more
  • qPCR
  • ELISA
  • Antibodies
  • ADCs
  • Ligand binding assays
  • ELISpot
  • Meso Scale Discovery
  • Luminex
  • NULISA
  • AlphaLISA
  • Hybrid LC-MS/MS
  • ddPCR
  • LC-UV-Vis/Fluorescence
  • ELISA Testing
  • ELISpot Testing
  • NULISA – Argo HT
  • Liquid Chromatography Mass Spectrometry
Scale and capacity
  • Kansas City headquarters and largest site
  • Philadelphia site: 26,000 ft² (2,500 m²) facility
  • Kansas City site: 70,000 ft² (6,500 m²)
  • More than 315 approved drugs on the market
  • More than 6,200 proprietary and non-proprietary assays
  • More than 20 FDA audits with no major findings
  • 25+ FDA inspections
Therapeutic areas
  • Allergy & Immunology
  • Cardiovascular
  • Dermatology
  • Gastrointestinal
  • Infectious Diseases
  • Inflammation & Pain
7 more
  • Metabolic
  • Neurology & CNS
  • Oncology
  • Ophthalmology
  • Rare Diseases
  • Renal
  • Respiratory

Instruments and platforms

  • Meso Scale Discovery
  • ELISA
  • ELISpot
  • Luminex
  • NULISA – Argo HT
  • AlphaLISA
6 more
  • Liquid Chromatography Mass Spectrometry
  • Hybrid LC-MS/MS
  • qPCR
  • ddPCR
  • Flow Cytometry
  • LC-UV-Vis/Fluorescence

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    Scope: development services

Details

Type
CRO
Address
10830 S. Clay Blair Blvd., Olathe, KS 66061
Sites
  • Kansas City, United States
  • Philadelphia, United States
  • Lyon, France
  • Melbourne, Australia
Serves
Global, United States, Europe, APAC

Similar labs